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Abstract: 
Accidental hypothermia is a rare condition with few deaths per year, but hypothermic 
patients have a 30% chance of dying. The past 15-20 years there has been an 
increased understanding of how hypothermia affects human physiology and may 
cause life-threatening conditions like arrhythmias, cardiovascular shock and 
pulmonary edema. New understanding of underlying mechanisms of hypothermia-
induced complications have led to new clinical guidelines and improved survival rates 
the last 20-30 years. This review will briefly focus on the underlying physical and 
physiological mechanisms for maintaining temperature homeostasis. The main goal is 
to give a detailed look on how hypothermia affect human physiology and give a 
review of the research done on the underlying mechanisms of hypothermia and 
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Man is a tropical endothermic animal not naturally adapted to live in cold 
environments. The thermo-neutral zone for a naked man at rest lies between 27ºC and 
31ºC and our optimal core temperature is 37ºC. Despite these limitations, we have 
conquered and settled in the most remote and cold places on the planet. In order to 
live and thrive in temperatures lower than 27ºC we have physiological mechanisms to 
produce heat and prevent heat loss. Our body saves heat by vasoconstriction and 
produce heat by increasing metabolism and muscle work. We have also developed 
(technical) equipment to help us keep warm and shelter us from nature. 
 
Hypothermia occurs when our body fails to react with the proper physiological 
response, when our equipment fails to shelter us from the cold, or when the forces of 
nature exceed our body or equipment ability to hinder heat loss. In physiology and 
medicine hypothermia is defined as a deliberate or accidental drop in core 
temperature below 35ºC. 
 
In my thesis description, I stated I would shed light on the clinical effect of 
hypothermia and the pathophysiological mechanism behind hypothermia/rewarming 
associated contractile dysfunction. I intended to base this on research done by my 
advisor Torkjel Tveita and his collaborators, including my own research.  
 
The main aim of this thesis is to describe the pathophysiological effects hypothermia 
has on human physiology and how hypothermia-induced organ dysfunction cause 
clinical challenges when treating hypothermic patients. Focus will be on to what 
extent hypothermia alters cardiac function and the consequences this may have for 
cardiac physiology, and for choices of drugs or invasive techniques when treating 
hypothermic patients. 
 
A secondary aim of this thesis is to look at hypothermia in a bigger picture than just 
physiological, pathophysiological and the clinical effects. The thesis will look at the 
physical mechanisms of how heat is transferred, how it is affected by climate and how 
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the body responds to cold. A final goal of this thesis is to describe the hypothermic 
patient.  
 
Due to the narrative form this thesis will not be able to draw a scientific conclusion 
based on objective observations. The conclusion will try to sum up the thesis with 
some key points on where the field of hypothermia is today and point out what 
knowledge is needed in the future to further improve survival of hypothermic patients.  
 
The paper will not focus on therapeutic hypothermia, but it is evident that many of the 
same physiological phenomena occur in both therapeutic and accidental hypothermia. 
Time will not be spent on explaining basic scientific principles and therefore the 
reader is expected to have a basic understanding of the classical scientific disciplines 
as well as an advanced understanding of medicine prior to reading this thesis. 
 
Methods and work process 
This thesis is a narrative based on information in papers and literature I have read as a 
part of my research the last four years. Much of the literature and publications 
originate from our laboratory at University of Tromsø.  
 
All work was done independently. Torkjel Tveita did revision on the final version of 
the thesis before submission. 
 
I have read the main body of supporting literature over a period of four years. I have 
worked with the experimental aspects of hypothermia research for some years and 
through this work collected most of the literature. Despite having read the literature 
on hypothermia before, I had to go through my library and re-read most of the articles 
to write this thesis. Since I choose to focus on the aspects of hypothermia outside my 
research, I had to explore and find literature on scientific fields of which I have no or 
little prior knowledge. I found it difficult to find and validate the strength of research 
in fields where I have little knowledge and my collection of literature has been 
collected in an unstructured manner.  
 
I had hoped to spend less time on writing than I did, but I ended up spending a full 12 
weeks on writing alone. I started out without a text disposition or a clear idea on what 
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the focus of the text should be. This resulted in several failed attempts and I ended up 
rewriting the thesis several times because of this. The final form of the thesis was 
chosen due to the natural progression from basic physiology, then pathophysiology, 
and ending up with clinical problems and treatment of hypothermia.  
 
I chose not to focus on my own research as I intended when I wrote my project 
description. The reason for this decision was made when I started to explore other 
branches of hypothermia to include in my general discretion of hypothermia. My 
research has in a large degree revolved around cell signaling pathways in cardiac 
muscle, but hypothermia contains many interesting aspects worthy of understanding. 
When I started writing, I discovered aspects of hypothermia I did not know before, 
but found interesting. I realized I wanted to explore these aspects further to get 
broader understanding about hypothermia and to put hypothermia in a bigger picture 
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Chapter 1: 
Thermodynamics and climate 
 
The human body strives to maintain homeostasis. Claud Bernard described the 
concept of homeostasis in 1865. Homeostasis comes from the Greek words 
“homoios” and “stasis” meaning “similar” and “standing still”. The concept of 
physiological homeostasis describes the complete process in which the human body 
strives to maintain the optimal microenvironment for its cells and organs. The fight 
for homeostasis can be seen between the cells and the rest of the organ, the organ and 
the organism, and the organism against the external environment. Homeostasis is 
achieved by tightly regulating everything from blood pH, glucose or electrolytes to 
body temperature. The branch of biology called physiology tries to explain how all 
these regulatory systems work together to maintain homeostasis in response to change 
in environmental factors The next chapter will go in depth on how the body senses 
and responds to changes in environmental temperature in order to prevent heat-loss. 
 
The human body has an extensive thermoregulatory system keeping us at an optimal 
core temperature. Thermoregulation is fundamentally based on the balance between 
thermogenesis and heat loss. A disturbance in this balance causes fever/heat shock on 
one side and hypothermia on the other. As describe above, if the hypothalamus senses 
an increase or decrease in body temperature, effector organs produce heat or increase 
heat loss, respectively(1).  
 
This chapter aims to describe the factors determining the homeostasis of temperature. 
The first part will explain the physical phenomena of heat-transfer and how different 
climate will affect the body’s ability to generate heat loss to the environment. The 
second and third part will focus on the how the body is able to sense temperature 
reduction and respond to maintain temperature homeostasis by thermogenesis or 
reduced heat loss.  
 
Physics and thermodynamics  
The relationship between heat production and heat transfer can be explained by the 
heat balance equation: (M-W) – (R+C+E) = S 
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Heat production or thermogenesis consists of metabolism (M) minus work done on 
the environment (W). Heat transfer consists of radiation (R), convection (C) and 
evaporation (E) together this sum up to net heat storage (S)(2). In the following 
chapter, I will explain in depth how the physical phenomenon transfers heat from or 
to our bodies. These physiological mechanisms are important to have knowledge 
about in order to understand how the thermoregulatory effector-organs work.  
 
Conduction 
Conduction is the process of heat-transfer directly from a place of high temperature to 
a place of lower temperature, without changing the material transferring the heat. 
Although heat transfer by conduction is mostly unimportant in normal physiological 
thermoregulation, immersion in water increase conductance by up to 4-fold. This will 
be discussed in more detail later. 
 
Radiation 
The transfer of heat by radiation is the release of electromagnetic waves in the 
infrared spectrum. The infrared waves are created when molecules randomly collide 
and emit photons. At higher temperatures increased rate of molecular collision 
increases photon emission and more heat is radiated to the environment. The 
environment also radiates heat upon us. The degree of radiation between the body and 
the environment can be described with a mathematical formula: 
 
The rate and direction of heat radiation R is dependent on the radiative heat-transfer 
coefficient (hradiative), the difference in temperature between the skin and the 
environment (Tskin-Tradiant) and on the area of the skin exposed to the environment 
(Aradiative)(2)  
 
Convection and wind chill effect 
Convection is the movement of heat by movement of a medium. The movement of 
warm blood from the core to the skin or the rise of heated air from the body are both 
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The rate and direction of heat convection I is dependent on the convection heat-
transfer coefficient (hconvective), the difference in temperature between the skin and the 
environment (Tskin-Tambient) and on the area of the skin exposed to the environment 
(Aconvetive). Like radiative heat transfer, the rate of convection is dependent on the 
difference between skin and environmental temperature. 
 
Convection can be classified as natural or forced(2). The rise of heated air is an 
example of natural convection. The removal by wind or a fan is an example of the 
latter. Forced convection is the explanation behind the wind chill effect. The rapid 
removal of the heated air increases convection and in a cold climate cools the body 
effectively(3). The wind chill effect can be described with the use of the wind chill 




This describes the relationship between the ambient temperature (T) and the wind 
speed in km/h (V). An example of this is if the air temperature is -10ºC and the wind 
speed 30km/h, the effective temperature experienced on the body will be -20ºC (4) . 
 
Evaporation and heat index 
Evaporation is the process of changing the physical form of a substance from liquid to 
gas. In physiology, this is usually limited to water evaporation. The process is energy 
consuming and evaporation alone can remove all excess heat produced during 
exercise. The energy removal during evaporation equals 58 kcal per 1g of water. The 
sweat glands can secrete 30g fluid /min or 1800g/hr. Evaporation can thus remove 
1000 kcal/h or 1,1kW from the body. This is a power drainage equivalent to that of a 
small electrical heater. Evaporation is the only heat exchange process dependent on 













Twc = 13.12 + 0.6215Ta −11.37V +0.16 + 0.3965TaV +0.16
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Since the rate of evaporation (E) is dependent on the gradient between skin humidity 
(Pskin) and ambient environment humidity (Pambient) the rate of evaporative heat loss is 
maintained even at high ambient temperatures. In humid environments, evaporative 
heat loss is reduced and heat storage increased. This effect is called heat index and 





This equation is a result of regression analysis and shows the effect of temperature (T) 
and relative humidity I on heat index(5). 
 
An example of heat index is the effect of throwing water on a hot sauna oven and feel 
how fast the air gets scolding hot. This is due to two factors: The first is due to our 
reduction in evaporation and reduction in heat loss due to increased air humidity. 
Secondly, humid air has a greater ability to store heat than dry air and makes it 
warmer.  
 
Heat index can also have the opposite effect. Due to the high heat capacity of humid 
air, cold humid air will absorb heat at a higher rate from the body. This is the 
explanation of why the relative temperature is colder when the humidity is high. 
 
Heat storage 
Our body strives to keep its core at a constant temperature. The result of the processes 
described above is heat loss or heat storage. With the knowledge of thermogenesis 
(M-W) and heat loss (R+C+E) we can calculate the net gain or loss in body 
temperature at different conditions. Since the specific heat of body tissue (0.83) is a 
constant and body weight (BW) normally spans from 50-150kg in the adult human 
being it’s the relationship between thermogenesis and heat loss that determine the net 












HI = −42.37 + 2.04T +10.14R − 0.22TR − 6.83x10−3T 2
−5.48x10−2R2 +1.22x10−3T 2R + 8.52x10−4TR2 −1.99x10−6T 2R2




If we study the formula more closely we notice that both hypothermia and 
hyperthermia can occur by an internal (M-W), external (R+C+E) heat load, or heat 
loss, or a combination of the two.(2).  
 
Internal heat load is created by increased heat production metabolism and work. 
Overheating occur when metabolism and heat production from work excides the 
body’s capacity to dissipate heat. This occurs in cases of severe fever or in 
overheating during exercise. Internal heat loss occurs when the body can´t increase its 
metabolism and thermogenesis to meet the requirements to maintain core temperature, 
even in environmental temperatures within the thermoneutral zone. This internal 
cause of heat loss is the basis of chronic hypothermia often witnessed in elderly and 
the chronically ill.  
 
External heat load or loss is determined by how the environmental factors change 
radiation, convection and evaporation. If these factors exceed the body’s ability 
compensate it is at risk of overheating or becoming hypothermic.  
 
Effects of climate on heat transfer  
The following scenarios illustrate how changes in weather and climate affect how 
heat is transferred from the body to the environment.  
 
Winter in Tromsø, Norway: The cold and humid environment 
In Tromsø, Norway, the combination of humid and cold climate is common during 
winter. Its climate is classified as subarctic by the Köppen climate classification. The 
mild winters with more precipitation are atypical compared to the classic subarctic 
climate description. The coastal climate prevents the temperatures to drop far below -
5ºC during winter and the average temperature in December is -0, 7ºC with a daily 







(M −W )− (R +C + E)
0.83 *  BW
kcal / h
kcal / (kg°C[ ]x kg

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November 27th to January 15th and the sun never sees the horizon. The coast of 
northern Norway is exposed to harsh winds from the Norwegian and Barents Seas. 
The city of Tromsø is naturally protected from these winds by mountains, but still has 
an average wind speed of 3,9 m/s in December. 
 
Radiation 
Because of ambient temperatures below freezing and no sunlight in the winter, the 
radiative heat load from the environment to the body is negative. The body thus loses 
heat by radiation.  
 
Convection 
Due to windy conditions all year around and the severe winter storms caused by the 
polar low pressures, the wind chill effect is important in northern Norway.  
 
Evaporation 
When the ambient temperature is low, the thermoregulatory system shuts down sweat 
production and secretion. However, in the case of a cold environment with high air 
humidity, the humidified water molecules easily condensates in contact with our skin. 
The water evaporates on the skin causing us to feel cold. 
 
Winter in Verkhoyansk, Russia: The cold and dry environment 
The coldest place on earth with a year around population is Verkhoyansk in the 
republic of Yakutia in eastern Russia. Verkhoyansk, like Tromsø, is in the subarctic 
climate category. Unlike Tromsø, Verkhoyansk is inland and dominated by year 
around high air pressure. These high pressures give a stable climate with very little 
precipitation and wind. The average precipitation during winter months is only 6 mm 
per month and the temperatures in January averages -47ºC. 
 
Radiation 
In these temperatures, the difference between body temperature and the environment 
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Evaporation 
Since there is no air humidity and heat index factor is absent, there is no condensation 
of air humidity on the skin and due to the low temperatures, there is no sweat 
contributing to heat loss.  
 
Convection 
Due a stable high pressure, there is little forced convection by wind, but the natural 
conductance still continues. Warmed air around the body rises and is replaced by cold 
air, contributing to convection. 
 
Immersion in water 
A common way to suffer accidental hypothermia is by immersion in water. During 
immersion, heat transfer by radiation and evaporation is reduced to almost zero. On 
the other hand, conduction is increased by 400%. Convection also increases if the 
water is moving. Heat loss is still dependent on the difference in temperature of the 
body and the water. The heat capacity of water is 70% higher than air, which increase 
the rate of heat transfer. All of these factors make immersing humans in cold water an 
effective measure of cooling and hypothermia occur rapidly(2).  
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Chapter2: 
Thermoception, thermoregulation and thermogenesis 
 
The last chapter focused on the fundamental thermodynamic phenomena the body has 
to relate to when regulating its temperature. Humans have evolved an elaborate 
system of thermoreceptors and effector organs to regulate its temperature. This 
enables us to sense temperature and the possibility of heat production, all controlled 
by the hypothalamus. The next chapter will focus on the molecular and physiological 
fundament on how the body defends itself against hypothermia by thermosensation 
and thermogenesis.  
 
 
Thermosensitive molecules and thermoreceptive neurons 
Thermoreceptors are found through out the body, but are mainly divided in peripheral 
and central receptors. This next section focuses on the difference between the 




The peripheral thermoreceptors in the skin consist mostly of cold receptors and to 
some degree warmth receptors. 
Signals from peripheral thermoreceptors are carried by both fast, myelinated, Aδ-
fibers and slow, unmyelinated, C-fibers. Cold receptors carry signals by Aδ-fibers 
and signals from the warmth receptors are carried by slow C-fibers. Slow C-fibers, 
and sometimes also fast Aδ-fibers, carry nociceptive and pain signals from both 
warmth and cold receptors(6).  
These fibers enter the spinal cord and synapses with interneurons on lamina I, II and 
V in the dorsal horn of the gray matter in the spinal cord. Then they cross the spinal 
cord at the same level as they enter and bundle together in the spinothalamic and the 
spinoreticulo-hypothalamic tracts (6) . Neurons carrying temperature signals can end 
up in two main areas of the brain: the insular cortex or hypothalamus.  
 
	   16	  
Insular cortex 
Signals ending up in the insular cortex are important in giving us a sensation of skin 
and visceral temperatures, and to discriminate and localized changes in temperatures. 
Before terminating in the insular cortex the signals follow the spinothalamic tract 
uninterrupted to the thalamus where it relays once in the posterior lateral area. A 
second pathway is possible with a double relay in the parabrachial nucleus in the 
brainstem and ventromedial nucleus of the thalamus.  
Hypothalamus 
The signals ending up in the hypothalamus are important in the homeostatic control of 
temperature. These signals follow the spinoreticulo-hypothalamic tract and end relay 
and integrate with dendrites of warmth-sensitive central thermoreceptors in the 
periventricular striatum and medial forebrain bundle before terminating in the 
preoptic anterior part of the hypothalamus(1,7). 
Central thermoreceptors 
In addition to the peripheral thermoreceptors the hypothalamus has its own 
thermosensitive neurons. The central thermoreceptors, unlike the peripheral 
thermoreceptors, consist almost solely of warmth sensitive neurons. These neurons 
have their soma in the preoptic anterior part of the hypothalamus and project their 
dendrites horizontally with one pole in the periventricular space by the third ventricle, 
and the second pole in the midbrain bundle. This orientation allows temperature to be 
monitored both close to the surface and in the viscera. When the cold sensitive 
neurons enter the hypothalamus they relay with these warmth sensitive neurons. The 
sum of these signals is interpreted by the hypothalamus as the body temperature. This 
makes determining a true core temperature difficult. Since the hypothalamus use 
signals from the whole body to determine body temperature, different parts of the 
body can have large variation in temperature. If the hypothalamus registers a 
discrepancy between the peripheral and the central temperature, or if the core 
temperature deviates from set point, relevant thermoregulating action are 
initiated(1,7).  
The transient receptor potential superfamily (TRP) 
The molecular background to understand how thermosensitive neurons work can be 
understood by looking at their use of the transient receptor potential family of proteins 
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(TRP). The TRP can be found in all thermosensitive neurons and the different 
subtypes of TRP determine the neurons sensitivity to different temperatures.  
These proteins are mixed, inward, cationic ion channels responding to changes in 
temperature. In cold receptors the influx of cations is increased inversely with 
lowered temperatures depolarizing the membrane at a higher frequency as 
temperature falls.(8) The TRP-channels have two important functions; the first is to 
detect changes in ambient environment and core body temperature. This information 
is important to make the correct physiological response in order to maintain 
homeostasis. The second function is to detect when the changes in ambient or body 
temperature reaches dangerously high or low levels. Some of the TPRs are able to 
change their signals from being evoked by cold or warm temperatures to pain or 
nociceptive stimuli (2). 
The most common TRP ion channel in cold receptors is TRP ankyrin 1 (TRPA1) and 
TRP melastatin 8 (TRPM8). The TRPM8 ion channel is also activated by menthol. 
This is why eating menthol or rubbing it on your skin gives a sensation of cold. The 
activity of TRPM8 follows a bell shape curve with low frequencies at temperatures 
above 40°C and below 17°C and a maximal firing rate at temperatures between 20-
30° C. Below 17°C the TRPA1-channel takes over cold signaling. This channel is not 
activated by menthol like the TRPM8, but is important in signaling nociceptive cold 
signals(7,8). 
Warmth-receptors are associated with other proteins in the TRP-family. Examples of 
these are TRPM2, 4, 5 and TRPV1-4. TRPV binds vaniloids. One of the chemical 
structures binding to this receptor is capsicin, the chemical making chili peppers hot, 
burning and painful. The warmth-receptors communicate the heat signal in the same 
manner as the cold receptors. The TPR-proteins open unspecific cation channels in 
response to increased temperature, depolarizing the neuron. The different heat 
sensitive TRP-channels react to temperature in a graded manner. The TRPM4/M5 
signal heat between 15°C -30°C, TRPV4: 28°C -40°C, TRPV3: 32°C -42°C, TRPV1: 
41°C -55°C and TRPV2: >50°C Warmth-receptors also acts as receptors for 
nociceptive signals. Nociception is signaled by TRPV1 and TRPV2(7,8). 
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Energy expenditure, thermogenesis and physiological and behavioral reduction 
of heat loss 
When the hypothalamus detects a reduction in ambient or core temperature, it triggers 
thermogenesis and heat saving mechanisms. Thermogenesis is an energy demanding 
process where chemical energy is utilized to release heat. This section will explore 
how the body utilizes different mechanisms to either produce heat or reduce heat loss.  
 
Energy expenditure can be divided in three main groups: obligatory energy 
expenditure, expenditure from physical activity and adaptive thermogenesis(9). 
 
Obligatory energy expenditure: 
Obligatory energy expenditure is the required energy to maintain normal cellular 
function in a resting human, not performing work in a thermo-neutral environment. 
This is the standard metabolic rate (SMR). The SMR can change depending on degree 
of body stress and strain. During starvation the SMR is reduced by up to 40%, and by 
10% during sleep(9). 
 
Physical activity: 
Expenditure from physical activity is the energy spent physically manipulating the 
surroundings. These processes all produce heat as a byproduct and contribute to 
thermogenesis. An athlete at VO2max spend 1300 kcal/h, out of this 70-85% is 
transformed to heat [ref]. 300kcal is used as work on the environment, for instance 
running or moving a heavy object. This is the heat we need to get rid off when we go 
for a run or do heavy work.  
 
Adaptive thermogenesis:  
The two groups mentioned above are functional groups where the end goal is cellular 
function and performance of work on the environment. Due to the nature of 
biochemical processes heat is produced as a byproduct. The adaptive thermogenic 
group only contributes to thermogenesis, but with as little effect on the environment 
as possible. The main effectors to produce heat are shivering, brown adipose tissue 
and diet-induced thermogenesis.  
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Shivering 
Shivering is controlled by its own primary motor center. This lies in the dorso-medial 
area of the hypothalamus, close to the third ventricle. It is inhibited by neurons from 
the pre-optic cortex. This area is excited by cold signals from the peripheral 
thermoreceptors. (10) . According to Horvath et al shivering starts when the skin 
temperature reaches 29°C, and general shivering starts at a skin temperature of 
27,1°C. Shivering creates heat by exciting both a muscle and its opposing antagonist. 
The creation of force causes heat to be produced by increased metabolic activity and 
ATP production. Shivering can increase global oxygen consumption 5-fold (11) , but 
is not nearly as effective in producing heat as physical activity. 
 
Diet-induced thermogenesis 
Diet-induced thermogenesis is a natural phenomenon occurring when digesting food. 
It is the result of the metabolic reactions taking place when digesting nutrients. Its is 
defined, according to Westerterp: “the increase in energy expenditure above fasting 
level divided by the energy content of the food ingested and is commonly expressed 
as a percentage”(12). 
 
Brown adipose tissue 
Although brown adipose tissue is almost non-existent in the adult human, it has been 
discovered by several investigators and is believed to take a small part in 
thermoregulation(13). It is important in thermogenesis in newborn and some animals. 
Brown adipose tissue is tangled in sympathetic nerve fibers. During a cold response, 
these fibers trigger the brown adipose tissue, via noradrenaline to trigger Uncoupling 
protein-1. This protein works in the mitochondria by allowing H+ to leak across the 
mitochondrial matrix. This results in lack of ATP production and increased metabolic 
action through glycolysis and Krebs cycle aimed at producing heat only(9). 
 
Behavioral changes and clothing 
As explained earlier, some of the temperature signals reach our consciousness and 
gives us a sensation of cold or warmth. Based on these signals we make behavioral 
changes. The precise manner of how these signals are transferred and interpreted is 
not known(1). Since our physiological mechanisms can't prevent heat loss outside of 
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the thermoneutral zone for an extended period of time, we have to take action. These 
changes vary from putting on clothes, lighting a fire or increase non-shivering 
thermogenetic activity.  
 
Clothing helps us prevent heat loss by protecting the body from wind and rain, 
reducing convective, evaporative and radiative heat loss. The most important effect of 
clothing is creating an air-filled space between the skin and the garment. This air 




Physiological heat preservation is triggered as the hypothalamus registers a fall in 
skin or core temperature. This is mediated through sympathetic nerves and causes 
peripheral vasoconstriction, reduced sweating and contraction of smooth muscle in 
hair on the skin giving us goose bumps(2). These are all measurements aimed at 
reducing the effect of radiation, evaporation and convection rather than increasing 
temperature. Vasoconstriction reduces convection of heat from the core to the skin 
surface. Radiation from the skin to the environment is lowered as peripheral blood 
flow is reduced. This peripheral vasoconstriction also aims to secure body 
temperature to the core organs like the brain and heart. The erection of dermal hare 




The last two chapters have shown how thermodynamics move heat from the body and 
how the body responds by manipulating thermodynamics or by thermogenesis. The 
sum of these processes is one’s body temperature. Hypothermia can develop through 
both external and internal causes. External hypothermia is caused by an 
overwhelming heat loss by extreme external factors and often occur to younger 
people having a skiing accident, falling asleep drunk outside or fishermen falling into 
the sea. Thermoregulation consequently tries to improve thermogenesis and stop heat 
loss, but fails. Internal hypothermia happens when the body cannot maintain 
homeostasis at “normal” temperatures, and occur mostly in chronically ill patients and 
elderly people
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Chapter 3 
Epidemiology of hypothermia 
 
Mortality data from the Center for Disease Control in the USA show that hypothermia 
was a low mortality in the population(15). With a death rate of only 0.30/100 000 per 
year hypothermia mortality is low compared to large killers like cancer or 
cardiovascular disease with an annual death rate of 184/100 000 and 191/100 000 
(16,17).  
Studies from the 1970s show an estimated lethality from hypothermia of 30-80%(18). 
Lately, studies show that total lethality has fallen to around 30%(19). Hypothermic 
patients are a heterogenic population and total lethality rate is a poor measure for the 
complexity surrounding chance of survival. The next chapter will focus on the 
heterogeneity among hypothermic patients and what defines the different groups of 
patients. 
 
The hypothermic patient 
Roeggla et al found in their data of 80 hypothermic patients in Vienna between 1991 
and 1998 that the mean age of patients of was 55 years of age. 52% of patients were 
male, 14% were homeless and 35% were found indoors . This is consonant with the 
findings of Megarbane et al in their data of 81 hypothermic patients. The mean age 
was 65 years of age, 50% were male, and 79% were found indoors . The total 
mortality of the hypothermic patients in data of Roeggla et al was 34%, versus 35% 
mortality in Megarbane et al. Van der Ploeg et al found the same among 84 
hypothermic patients in Amsterdam, Netherlands. In their data 84% is male with a 
mean age of 47 years of age. 22% was found indoors(20). The total mortality rate is 
similar to that of Roeggla and Megarbane with 28%. 
Taylor et al found, based on autopsy data from 63 hypothermia deaths in Alabama, 
USA, occurring between 1983 – 1999, that death by hypothermia falls within two 
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The old and comorbid found indoor versus the young intoxicated found outdoors 
The three studies mentioned above show that 22% - 35% of hypothermic patients are 
found indoors. According to Roeggla et al the mean age of the patients found indoors 
was 69 years versus 50 years in those found outdoors. Also Megarbanes et al found 
similar numbers with a mean age of 67 years in those patients found indoors and 42 
years in those found outdoors. They found that the patients found indoors had a 
significantly higher rate of associated illnesses. 19% were alcohol or drug intoxicated 
30% had septicemia, 27% had neuropsychiatric disorders, 13% had 
hypothyroidism/hypoglycemia, 5% had cardiac arrhythmias, and 6% had other 
unspecified pathological states. In the victims found outdoors, the associated illnesses 
were significantly different. 76% of the patients had alcohol or drug intoxication, 6% 
had septicemia, 12% had neuropsychiatric disorders and 6% had 
hypothyroidism/hypoglycemia. The mortality in the indoors group is significantly 
higher than the patients found outdoor(22). Megarbanes et al. found a mortality rate of 
44% in the indoor versus 6% in the outdoors group(22). Roeggla et al showed a 
mortality of 81% in the indoors group against 11% in the outdoors group(19).  
The discrepancy in mortality between the outdoors and indoors group has been 
written off due to the large numbers of comorbidity and the high age among the 
patients found indoors(19,22). Elderly patients have altered responses to changes in 
temperature. They have a lower tendency to induce thermoprotective measures, to 
prevent heat loss, and to start thermogenesis(23). This predisposes the elderly to 
chronic hypothermia. The elderly have a higher rate of comorbidity, which predispose 
them to hypothermia and to complications during rewarming.  
In patients found outdoors, evidence of alcohol or drug intoxication was found in 76% 
of them. An explanation of the lower mortality might be the protective effect on 
alcohol on cardiac function during hypothermia , but studies have not shown a 
correlation between blood alcohol level and improved survival in hypothermia 
patients  
Trauma patients 
Hypothermia is common among trauma patients and it is found to be an independent 
risk factor for death in trauma patients (24,25) . Wang et al found that 9,7% of their 
hypothermia patients had an additional trauma and not solely du to environmental 
	   23	  
exposure(26). In the study by Van der Ploeg et al 47% of the hypothermia diagnoses 
were associated with trauma(20). Trauma patients are prone to hypothermia, these 
patients often suffer from conditions that impair their ability to reduce heat loss and 
produce heat by shivering or activity. Unconsciousness, hemorrhage, hypoxia and 
hypo-perfusion are all important factors predisposing trauma patients to hypothermia 
(27) . Wang et al found that the group of trauma patients with highest percentage of 
hypothermia was the second most traumatized group with a injury severity score 
between 3,5-4(26). Martin et. al found that among all of trauma patients in the US 
National Trauma Data Bank between 1993 – 200,5 1,9% where hypothermic. 
Mortality rate of hypothermic patients was 25% versus 3% in the patients with a core 
temperature >35ºC(28). Wang et al showed a linear relationship between degree of 
hypothermia and mortality in traumatic patients, with 100% mortality at core 
temperature <32ºC (26) . In Melbourne, Australia, Ireland et al found that 13,25% of 
737 trauma patients were hypothermic upon hospital admission. A mortality of 29,9% 
was found in these patients versus 5,98% in non-hypothermic patients(25). In addition 
to having higher mortality, trauma patients stay longer in hospital and have a lower 
chance of being discharged to their home(25). 
Summary 
The data presented show that the lethality of hypothermia depended on other factors 
than just body temperatures. The victims of hypothermia are a heterogeneous group 
and survival rate is dependent on cohort. Age, comorbidity and associated traumatic 
accidents are all important factors when determining the severity of a hypothermic 
patient.  
Few studies have looked at the interplay between factors like age, comorbidities, 
intoxication, and hypothermia. Thus, there is little knowledge about how the 
underlying mechanisms of hypothermia interact with the mechanisms of additional 
conditions.  
This body of epidemiological data shows the importance of temperature measurement 
and prophylactic treatment against hypothermia in traumatized patients. Preventing 
hypothermia in the traumatic patient is key to improving survival rates and 
rehabilitation of these patients (24) .  
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Chapter 4:  
The physiological effects of hypothermia 
Human physiology is affected by hypothermia in a graded manner(29). Earlier 
clinical descriptions of grades hypothermia were based on its effect on human 
physiology with an emphasis on neurological symptoms and level of consciousness, 
and not on the clinical significance and complications of hypothermia(30). This 
chapter will focus on how human physiology is affected by hypothermia. The first 
part will elaborate on how hypothermia is defined and how it is graded. The 
remaining parts of this chapter will focus on how hypothermia affect individual organ 
systems and how this gives rise to clinical complications. 
 
Grading of hypothermia 
The grading system by Popovic from 1974 defines hypothermia as a core temperature 
below 35°C, and the international community across scientific branches still agrees on 
this definition of hypothermia(30,31). Although there is an international consensus 
about the definition of hypothermia there is still discrepancy on grading. Popovic 
divided hypothermia in mild (35°C- 32°C), moderate (32°C-22°C), deep (22°C- 8°C) 
and profound (< 8°C). Later Danzel, in 1994, divided hypothermia in mild (35°C -
32°C), moderate (32°C - 28°C), severe (28°C - 20°C), and profound (< 20°C)(32). 
This scaling is used in the European Resuscitation Council’s guidelines for treating 
hypothermic patients. In 2009 Polderman and Herold proposed a more simplified 
scaling (33) . Mild hypothermia between 35°C - 34°C, moderate 34°C - 30°C, and 
severe < 30°C. This is the grading used by the American Heart Association and in the 
new University Hospital of Northern-Norway 2014 guidelines for treating accidental 
hypothermia (34,35). Poldermans grading is used because 30°C is acknowledged of 
as an important temperature in the clinical setting by grading anything below 30°C as 
severe. Rather than using Poldermans more clinical relevant grading system, I will 
use Danzels grading from 1994 when explaining the effects of hypothermia on the 
human physiology. The main difference between these to systems is that rather than 
focusing on the clinical aspects emphasizing 30°C as a critical temperature, Danzel is 
focusing on the physiological effects of hypothermia at different temperature intervals 
all the way down to and below 20°C.  
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Cellular changes 
Hypothermia is unphysiological and damaging state and the body takes measures to 
protect itself from hypothermia. Hypothermia affects our cells with respect to cellular 
structure, ion handling and metabolism(36). Prolonged hypothermia damages cellular 
cytoskeletal and membrane integrity(37). The mechanism behind this is unknown, but 
change in the reactive oxygen species (ROS) balance and increased ROS production 
is believed to be important(36). An increase in ROS production is known to damage 
cellular structures(38) 
 
Ion handling is affected by the reduced enzymatic Na+/K+-ATPase activity. This 
result in increased intracellular [Na+]. Some investigators advocate other underlying 
mechanisms to explain the increased [Na+]i.. Boutilier ascribes it to increased H+/Na+-
antiporter activity (36). Regardless of the underlying cause of increased [Na+]i, this is 
an important pathophysiological phenomenon leading to cytosolic calcium 
overload(36) and further cellular dysfunction.  
 
Reduced enzymatic activity in glycolysis, Krebs cycle and oxidative phosphorylation 
during hypothermia impair cellular metabolism (39). Although different cell types 
differ in how they metabolically react to hypothermia, the general rule is that 
metabolism is reduced with 6% per 1ºC. At 28ºC metabolism is reduced 70-80%(29).  
 
Cardiovascular system 
The initial response by the body to hypothermia is a sympathetic drive causing 
tachycardia, peripheral vasoconstriction and increased cardiac contractility, resulting 
in increased cardiac output and oxygen consumption(14,40,41).  
 
When temperature is lowered further bradycardia sets in, cardiac output and blood 
pressure are both reduced. At 28ºC heart rate is reduced by 50%, this severe 
bradycardia is due to reduced sympathetic activity by the autonomic nervous 
system(14). This in combination with reduced contractile function will significantly 
impair cardiac output. The molecular basis for this has been proposed to be decreased 
ATP production and reduced myofilament calcium sensitivity(42-44). When the 
sympathetic activity is reduced at <28ºC the vascular tone goes down. Due to the 
reduction in cardiac output the body depends on compensatory vasoconstriction to 
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maintain perfusion pressure. Reduction in vascular tone prevents this compensation 
and causes peripheral vasodilatation and a reduction in perfusion and blood pressure. 
 
The electrophysiological changes due to hypothermia are clinically important and 
give rise to arrhythmias and, finally, asystole. At the onset of hypothermia there is 
little change in electrophysiology, but as the heart is cooled to 31ºC the conduction 
velocity of the heart is reduced as well as the repolarization, but the activation speed 
of the ventricle remains unchanged(45). This is reflected on an ECG as a prolongation 
of the PR-interval, the QT-time and a broadening of the QRS complex(41). In 
addition, reduced repolarization can be seen as a “J” or “Osborne” wave on an ECG, 
but has little clinical significance(46). The cellular basis for the reduced conduction 
and repolarization speed is not yet fully understood. Reduced enzymatic activity and 
the lower production of ATP, due to hypothermia might be an underlying mechanism. 
This would slow the Na+/K+-ATPase and hinder repolarization. Hypothermia also 
reduces the opening and closing of sodium channels, which slows the conduction of 
the Purkinje fibers(47). 
 
The fibrillation threshold is lowest at around 30ºC. The mechanism behind this 
increased susceptibility to arrhythmias, and why it is greatest around 30ºC, is not yet 
fully understood(45). Reduced conduction speed in the ventricles versus the atrium, 
due to the slow nature of Purkinje fibers, might trigger a desynchronization between 
the atrium and the ventricles. The slowed repolarization in combination in with 
normal ventricular activation time at 31ºC might cause early after-depolarizations. 
These can trigger torsades de pointes, ventricular tachycardia or fibrillation (48) . 
Interestingly, at 17ºC conduction velocity, repolarization and ventricular activation 
time are all decreased and the fibrillation threshold is increased to normothermic 
levels. This suggests that the cause of the pro-arrhythmic state seen at 31ºC lies in the 
mismatch between repolarization, conduction velocity and activation time (45). 
 
Respiratory system 
The sympathetic drive at onset of hypothermia manifest itself initially as tachypnea, 
bronchial dilation, increased minute volume, and hyperventilation. As hypothermia 
progresses the respiratory center in the brain is depressed. At 34ºC sensitivity to CO2 
is reduced and, in combination with reduced CO2 production, impairs spontaneous 
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respiration. The peripheral oxygen sensitive receptors in the aortic arch are still 
functioning at low temperatures. This ensures a working hypoxic respiratory drive 
which help stimulate the respiratory center and maintain spontaneous respiration. 
Around 25ºC spontaneous respiration eventually stops and apnea occurs(14).  
 
At moderate hypothermia the ciliary function in the airways are impaired, 
predisposing to aspiration and pneumonia. When cold narcosis occurs at 30ºC, the 
protective airway reflexes become inoperative. This leaves the airways defenseless 
against aspiration and airway collapse(14,29,41).  
 
There is little change in gas exchange during hypothermia, but there is an increase in 
anatomical and physiological dead space due to bronchial dilation.(49). These 
changes are small and not considered to contribute as a complication factor. 
Pulmonary edema has been reported, but is uncommon(41).  
 
Acid-base balance 
Hypothermia is associated with an acidotic state(50). The mechanism underlying the 
acid-base disturbances is bipartite, both respiratory and metabolic(51). With respect to 
the respiratory mechanism, hypothermia affects the chemical properties of CO2.A 
decrease in temperature increases the solubility of CO2. This shifts the chemical 
equilibrium between CO2 + H2O and HCO3- + H+ towards the right, producing more 
H+. The limitation of H+ production is the rate of dissociation of CO2+H2O. Reduced 
temperatures lower dissociation rates, but this effect is not strong enough to hinder H+ 
being formed. The net result of these changes is a decrease in pH. 
 
The physiological result of severe hypothermia is respiratory depression with 
reduction in alveolar ventilation. This causes CO2 to be retained increasing H+ 
production(14,51). 
 
The metabolic component is the result of lactate production from shivering and 
lowered tissue perfusion and reduction in liver enzyme conversion of lactate(51). 
 
Endocrine system 
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The endocrine system reacts to immediate hypothermia by increasing metabolism and 
thermogenesis. The endocrine effector organs release thyroid hormones, cortisol, 
glucagon and catecholamines. This increases blood glucose, free fatty acids, inhibits 
insulin production and peripheral insulin responsiveness resulting in initial 
hyperglycemia(52). During prolonged and deeper hypothermia <28C the 
endocriological effector organs stop working. Shivering use glucose and during 
cooling this glucose is consumed, this in combination with impaired gluconeogenesis 
by the liver cause hypoglycemia. This can be observed after only a brief period of 
hypothermia(11,41). Since the blood glucose is not only dependent on 
gluconeogenesis and insulin production, but also on the metabolic rate of the patient, 
the rate of shivering and physical activity is important in determining how fast 
glucose is spent. Although most patients are hypoglycemic, clinical data show large 
differences between patients in blood glucose and insulin levels(14,41). 
 
Cortisol, thyroid hormones and catecholamines levels are often unchanged and within 
the normal range during prolonged hypothermia, and may even be increased during 
rewarming(53). An explanation might due to a reduction in hormone release and, at 
the same time, an increase in hormonal half-time due to slowed drug and hormone 
metabolism during hypothermia.  
 
Renal system 
A major complication of hypothermia is cold-diuresis. It is one of the first clinical 
signs of moderate hypothermia and can increase urinary output 3-4 folds. The 
mechanism behind the increased renal output is still debated. The two main theories 
are hypervolemia and hyperosmolality. The hypervolemia theory claims that due to 
peripheral vasoconstriction there is a relative increase in blood pressure, which is 
detected by the renal and central autoregulation. The production of anti-diuretic 
hormone (ADH) from the pituitary is reduced and less water is reabsorbed in the renal 
collecting ducts(41,54). 
 
The metabolic rate of the kidney is very susceptible to temperature. At <20C the 
metabolic rate is close to zero. The reduction in metabolism and subsequent oxygen 
consumption lowers enzymatic rate, hindering renal reabsorption of electrolytes. The 
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osmolality theory claims that the reduced metabolic rate in the kidney reduces 
reabsorption of the ultrafiltration. This results in osmolal diuresis. (41) .  
The impaired renal metabolism contributes to the metabolic acidosis by reducing both 
HCO3- production and H+ excretion.  
 
Kidney failure is seen in 40% of hypothermic patients. The underlying mechanism 
has been attributed to prerenal causes, primarily due to hypothermia-induced 
hypoperfusion during rewarming. The kidneys are protected from hypoxia during 
hypothermia, but during rewarming there is a miss-match between oxygen 
consumption and demand causing acute tubular necrosis(41,55)  
 
Hematology and coagulation 
Hypothermia affects hematology in two important matters: The first is increased 
viscosity and hemoglobin concentration. Due to increased capillary leakage and cold-
diuresis there is a loss of plasma volume, thus increased hematocrit(56). The 
hematocrit is increased with 2% for every 1ºC decline in body temperature. At 
temperatures in the severe range, the hematocrit can reach numbers as high as 
50%(14,41). 
 
Coagulation is affected by hypothermia. The coagulopathy caused by hypothermia is 
a feared complication and one of the reasons that hypothermic trauma patients have 
such high mortality compared to normothermic patients(27). Hypothermia affects 
coagulation by altering platelet aggregation and adhesion, but not platelet activation 
time. Platelet function is reduced by 33% at 33ºC, and do not worsen upon further 
cooling. How hypothermia cause decreased platelet aggregation and adhesion but not 
reduce the activation of platelet is not fully understood. Reduced thromboxane A2 
synthesis have been proposed as one possible mechanism(57). Hypothermia can also 
induce thrombocytopenia due to platelet sequestration in the liver and spleen, as well 
as impaired hematopoiesis due to bone marrow suppression.  
 
Moderate hypothermia do not significantly increase aPTT or INR(57). Studies have 
shown reduced enzymatic activity of individual coagulation factors at in moderate 
hypothermia. Despite the reduced enzymatic activity there is only a minor reduction 
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in aPTT and INR. At temperatures below 33ºC both aPTT and INR are significantly 
reduced and continues to increase down to 25ºC(57). 
 
The clinical consequence of alternation of hematology and reduced coagulation 
activity during hypothermia is grave and feared(27). The reduced platelet activation 
and increased aPTT and INR make hemostasis in hypothermic a major difficult when 
treating bleeding hypothermic patients.  
 
Summary 
The previous chapter covered the effects of hypothermia on the major organ systems. 
The introduction advocated grading hypothermia with the scale used by Danzl, as this 
focus on the pure physiological phenomena occurring during hypothermia, focusing 
less on the clinical significance of the changes. 
In the clinical setting, this grading is too complex and a less complicated one is 
needed. The acknowledgement of 30ºC as clinically important by Polderman and in 
new guidelines is based on the pathophysiological changes explained in this chapter. 
It seems that the physiological compensatory mechanisms are able to answer to 
changes caused by mild hypothermia. At around 30ºC these mechanisms are unable to 
maintain homeostasis and make way for life-threatening complications: loss of 
consciousness, the cardiovascular system fail to provide sufficient perfusion pressure, 
our endocrine system fails to maintain glucose and electrolyte balance, blood 
coagulation fails and our respiratory system and renal system cannot manage the 
excess H+ resulting in acidosis.   
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Chapter 5: 
Hypothermia-associated contractile dysfunction - “rewarming shock” 
 
Rewarming from hypothermia is associated with several severe complications. Our 
research group at the University of Tromsø has since the early 1990s studied effects 
and pathophysiologic mechanisms of hypothermia-associated contractile dysfunction 
or “rewarming shock”. Napoleon’s army’s chief surgeon, Moricheau-Beaupré, first 
described symptoms of rewarming shock in 1812. He described those patients who 
were rewarmed from severe hypothermia to suffer a vascular collapse with low blood 
pressure and hypoperfusion just prior to reaching 37ºC. Despite being described as 
early as 1812, little light has been shed on the underlying mechanism or treatment of 
“rewarming shock”. Rewarming shock is an important complication when rewarming 
patients and one of the factors responsible for the high mortality(58). 
 
Tveita et al conducted several experiments in the early and mid-1990s to describe 
rewarming shock and its effects on the heart and on global cardiovascular physiology. 
The next chapter will elaborate on this  
 
Cardiac contractile function 
Rewarming from hypothermia is associated with depressed cardiac contractile 
function. In vivo rat studies showed a reduction in cardiac output (CO) and stroke 
volume (SV) of 50% when rewarmed after 4 hours of hypothermia at 15ºC. Arterial 
pressure after rewarming remained unchanged, but total peripheral resistance was 
increased by 50%(59). Another rat experiments, aimed to look at blood composition 
and distribution after rewarming, showed a slight reduction in plasma volume, but not 
a significant change in blood volume. The plasma colloid pressure was also increased, 
indicating fluid loss. The distribution was significantly reduced in all tissues after 
rewarming(56). 
 
Cardiac depression was also found in dogs after rewarming. 8 dogs where cooled, 
from 37ºC to 25ºC, and then rewarmed to 37ºC. This resulted in a reduction in mean 
aortic pressure (MAP), stroke work (SW) and preload-recruitable stroke work 
(PRSW) after rewarming, indicating hypothermia-induced cardiac dysfunction. 
Diastolic function was measured with the isovolumetric relaxation constant (τ), and 
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showed no difference after rewarming compared to baseline, indicating a preserved 
diastolic function(60).  
 
Metabolism and ATP production 
As explained earlier, hypothermia is known to reduce metabolism in eukaryote cells. 
The reduction in metabolism is improved upon rewarming, but Tveita et al showed a 
continued reduction in ATP production in cardiac cells upon rewarming(43). 
 
A common cause to reduced ATP production is hypoxia, as it leads to ATP 
production from lactic acid, which yields less ATP. Kondratiev et al investigated 
oxygen delivery in tissue during hypothermia and rewarming. They found that oxygen 
was not a limiting factor when rewarming rats after prolonged hypothermia, with 
regard to cardiac function(61) 
 
Change in metabolic substrate from fatty acids to glucose will also reduce ATP 
production per mole of oxygen in cardiac cells. Steigen et al. investigated the effect of 
hypothermia/rewarming on the myocardial capability to utilize fatty acids in oxidative 
phosphorylation. Fatty acid oxidation is often used as an indicator for cardiomyocyte 
health and metabolism(62). Cardiomyocyte damage and stress cause a shift in 
metabolic substrate from fatty acids to glucose (62). Steigen et al found a reduction in 
fatty acid and glucose oxidation during hypothermia. After rewarming, fatty acid 
oxidation was still reduced, while glucose oxidation was normalized. A second study 
preformed on isolated rat hearts found the same reduction in glucose and fatty acids 
during hypothermia, but after rewarming both glucose and fatty acid oxidation were 
reduced(63). In both these experiments cardiac function was depressed upon 
rewarming(63). Based on these finding Steigen concluded that cardiac dysfunction 
during rewarming is independent of cardiac substrate specificity(64).  
 
The exact mechanism why metabolism is reduced when rewarming is still unclear. A 
possible explanation is mitochondrial dysfunction induced by hypothermia. 
Rewarming from hypothermia has proven to induce mitochondrial swelling, calcium 
overload and cytochrome C release. These are all factors indicating mitochondrial 
damage.  
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Myocardial ultrastructure 
To investigate the effects of hypothermia on the integrity of myocardial cells Tveita 
el. al analyzed myocardial ultrastructure after rewarming using an electron 
microscope. They found a 72% increase in myocyte cytosolic volume and 
mitochondrial swelling by 42%. Investigations on the mitochondria showed 
mitochondria alteration of 48% in the rewarmed group(65). They argue that cellular 
swelling is a sign of increased [Na+]i. Although the exact mechanisms behind the 
increased [Na+]i is still unknown, the reduction in Na+/K+-ATPase enzymatic activity 
have been proposed as the main mechanism. Some investigators point to other 
possible cellular mechanisms. Boutilier emphasize on the effect of cellular acidosis on 
the H+/Na+-antiporter (36) . A known result of increased [Na+]i is the increase of 
[Ca2+]i due to the influx of Ca2+ through the Na+/Ca2+-exchanger. Calcium overload 
can be seen in ischemia-reperfusion experiments, and is associated with reduced 
myocyte contractile function and cell viability(66). Kondratiev and Wold showed this 
increase in [Ca2+]i in animals after rewarming from hypothermia(67,68). 
 
Kondratiev and Wold found an increase in global intracellular calcium at onset of 
deep hypothermia. After four hours at 15ºC, there was a six-fold increase in 
intracellular calcium compared to before hypothermia. When rewarmed the calcium 
levels seemed to reduce, but there was no significant change in [Ca2+]i between the 
hypothermic and the rewarmed rats (67,68) .  
 
Dysfunctional β-receptors 
Functioning β-receptors are important in maintaining cardiac function during 
physiological stress. Studies have been conducted with focus on the effect of 
epinephrine on the myocardium and probable alteration of the β-receptor during and 
after hypothermia. Studies done by Kondratiev and Han showed an altered response 
to epinephrine during and after hypothermia(69-71). When compared to 
normothermic controls a high dose of epinephrine (1,65ug/kg/min) increased mean 
arterial pressure, indicating epinephrine dependent vasoconstriction, with 
simultaneous absence of inotropic effect. Lower doses (0,4-1,25ug/kg/min) of 
epinephrine where able to produce an increase in cardiac output, but there was still a 
significant increase in total peripheral resistance compared to normothermic rats 
given epinephrine. Kondratiev concluded that these results are due to a mismatch 
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between β and α-receptor potency. During rewarming the α-mediated vasoconstrictive 
effect of epinephrine on vascular smooth muscle seems to be more potent that the 
positive inotropic effect of the β-agonism myocardium.  
 
Han et al later studied the effect of the β-specific agonist isoprenaline before, during 
and after hypothermia(69). His findings correlated with Kondratievs, showing a 
decreased effect of β-stimuli on the heart after rewarming from hypothermia. He 
showed that at baseline rats exhibited a graded response to isoprenaline by increased 
CO, SV, HR and reduced TPR.  Isoprenaline fail to produce the same response in rats 
during rewarming from hypothermia.  
 
Isoprenaline cause vasodilation in the peripheral vessels, reducing vascular resistance. 
This was seen when isoprenalin as given to normothermic rats. After rewarming this 
effect was no longer present, even with a high dose (66 ng/kg/min). These data where 
interpreted by Han. et. al to indicate a failure in the β-reseptor cascade in vascular 
smooth muscle, creating an high vascular resistance. The reduction in cardiac 
contractility at low doses can also indicate β-reseptor desensitization in 
cardiomyocytes after hypothermia.  
 
Altered myofilament calcium sensitivity  
Han et al later showed in isolated papillary muscles a reduction of myofilament 
calcium sensitivity after rewarming from 1,5 hours of hypothermia. They showed that 
rewarmed isolated papillary muscle produced less force at higher Ca2+ levels than 
their controls. Lowering temperature is known to reduce myofilament calcium 
sensitivity(42). Han et al showed that the reduction is still present after rewarming. 
They looked at cardiac troponin I phosphorylation (cTnI) at the calcium sensitivity 
regulating sites Serine 23/24 on cTnI (72). They found a 40% increase in cTnI 
Ser23/24 phosphorylation after rewarming. Ser23/24 is a site, which is highly 
phosphorylated by protein kinase A (PKA), a downstream β-receptor second 
messenger. There is, seemingly, a conflict between the theory of β-dysfunction and 
cTnI-hyperphosphorylation. In normal physiology, Ser23/24 is mainly phosphorylated 
by PKA. After rewarming from hypothermia there is an increased Ser23/24 despite an 
apparent β-receptor dysfunction(44). This indicates a hypothermia-induced 
	   35	  
mechanism causing increased Ser23/24 cTnI phosphorylation, other than downstream 
β-receptor stimulation. 
 
Preliminary data from Haaheim et al have shown that the calcium activated Protein 
Kinase C (PKC) phosphorylate Ser23/24 during rewarming from hypothermia in 
mice(73). Cross-phosphorylation of PKC to Ser23/24 is unimportant in the normal 
physiology(74), but in hypothermia it seems to play a crucial role in Ser23/24 
phosphorylation and thus myofilament calcium sensitivity.  
 
Summary 
The data and studies presented paint a picture of what happens to the heart during 
rewarming from hypothermia. It has become evident that the main component of 
“rewarming shock” is myocardial contractile dysfunction. The causal mechanism is 
unclear and multiple explanations exist. The most popular theories are: 1) 
Mitochondrial dysfunction due to mitochondrial and cellular calcium overload, 
resulting in subsequent reduced ATP production. 2) Reduced calcium sensitivity due 
to dysregulation of myofilament phosphorylation, reducing the amount of force 
produced at a given [Ca2+]i. 3) Impaired calcium handling, causing cellular calcium 
overload. 4) β-receptor dysfunction hindering a positive inotropic effect of 
epinephrine.  
 
Continued investigation and search for these underlying mechanisms is needed to 
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Chapter 6 
Treatment of hypothermic patients 
 
There has been a lack of consensus in the clinical community on how to treat 
hypothermic patients. In recent years, new guidelines have been written with 
emphasis on techniques and speed of rewarming. Both the European Resuscitation 
Council (ref) and American Heart Association came out with new guidelines 
2010(31,34), and The University Hospital of Northern-Norway published their new 
guideline for rewarming from accidental hypothermia January 2014(35). These 
guidelines all emphasize on the importance of: “no patients is declared dead before 
they are warm and dead”. This is based on clinical empirics where patients have been 
rewarmed from as low as 13,7°C and survived with close to no neurological 
sequel(75). Hypothermic patients with cardiac arrest should be treated with the same 
CPR algorithm with regard to compression technique and rate of ventilation. There is 
still debate regarding the use of vasopressors, fluid support, and inotropic and 
antiarrhythmic drugs in treating hypothermic patients. This chapter will elaborate on 
the different techniques of rewarming and the scientific evidence for use, or 
withholding the use, of these drugs. 
 
Rewarming techniques 
Rewarming from accidental hypothermia can be performed in several manners. The 
two main categories are invasive and non-invasive devices. Non-invasive methods 
like hot fluids to the skin and warm air blankets are the most common methods. These 
methods are easy to use, and non-invasive. The drawback is that they are not as 
efficient as invasive techniques and the patients need to be able to support their own 
circulation to distribute the rewarmed blood. 
 
There are several invasive techniques to rewarm hypothermic patients. The most 
efficient, but also most invasive, are extracorporeal membrane oxygenation (ECMO) 
and cardiopulmonary bypass (CPB)(76). The advantage with ECMO/CPB is that they 
can support circulation and oxygenation in addition to extracorporeal rewarming of 
the blood. Other invasive methods are infusion of warm fluids, and thoracic and/or 
peritoneal lavage. Thoracic lavage has shown to be an effective rewarming technique 
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in patients with stable circulation and in some cases of ventricular fibrillation and 
hypo perfusion . Infusion of fluid is not recommended as a rewarming method due to 
lack of effect and slow rewarming speed(35). The University Hospital of Northern-
Norway just released their new guidelines for rewarming patients from accidental 
hypothermia. The recommendation is to treat hypothermic patients with body 
temperature >28ºC with stable circulation (>90 mmHg and sinus rhythm) using non-
invasive rewarming methods. Since the primary hospitals in Northern-Norway do not 
have ECMO/CPB capability, patients with unstable circulation or body temperatures 
<28ºC are transported to Tromsø to be rewarmed on ECMO. Some investigators 
propose to use thoracic lavage when EMCO/CPB is not available and have shown 
good results in mortality and neurological outcome amongst survivors(77,78). Due to 
the lack of cardiopulmonary support in thoracic lavage and the high success rate in 
ECMO/CPB, thoracic lavage is considered an emergency solution. ECMO/CPB 
treatment in hypothermic patients with cardiac arrest has a success rate of 47%(76) 
and is thus the recommended treatment. 
 
Drug therapy 
An important part of critical care medicine is the support of vasoactive drugs and 
fluids infusions. Both the European Resuscitation Council and American Heart 
Association came out with new guidelines in 2010 with regard to cardiopulmonary 
resuscitation(31,34). They both advice withholding epinephrine and amiodarone in 
patients with cardiac arrest and a body temperature <30ºC. Northern-Norwegian 
guidelines, as well as the guidelines from University Hospital of Oslo, agree with this 
recommendation. In the case of hypotension and contractile dysfunction, they 
recommended the use of dopamine as the inotropic drug of choice. They recommend 
not using anti-arrhythmetics since these drugs have shown to have no effect on 
preventing the incidence of ventricular fibrillation in hypothermic patients with 
spontaneous circulation. With regard to fluid support, the recommendation is to use 
Ringer-Acetate and withhold the use of NaCl. The basis of this is the fear of 
worsening of metabolic acidosis by adding chloride(35).  
 
Our research group at the University of Tromsø has over the last 25 years tested 
whether the commonly used drugs in critical care improve hemodynamic function in 
hypothermic animals. There has been a large focus on the use of inotropic drugs, with 
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a sharpened focus on beta-agonistic drugs like epinephrine. Studies on fluid support, 
anti-arrhythmic and other inotropic drugs have also been conducted. The last chapter 
in this thesis will focus of these findings and their clinical application. 
 
Vasoactive drugs: 
The previously explained findings of Kondratiev and Han on how epinephrine and 
isoprenaline affect hemodynamics and cardiac function during hypothermia and 
rewarming. They showed detrimental effect of a high dose of epinephrine during 
hypothermia and after rewarming(69,70). Later Filseth. et al showed a beneficial 
effect of dopamine during rewarming in pigs(79). Dopamine increased CO and 
reduced TPR with no change in MAP in pigs at 34 and 38ºC during rewarming after 1 
hour at 25ºC. This indicates a beneficial effect of dopamine by increasing cardiac 
output while at the same time reducing vascular resistance.  
 
As explained earlier Tveita et al found an increase in TPR after rewarming in 
untreated animals. A high TPR creates an increased afterload and is generally 
detrimental to the CO. To investigate the role of TPR on CO during rewarming, our 
laboratory utilized nitroprusside and diltiazem to reduce TPR during rewarming. 
Preliminary data from these experiments showed no improvement in CO after 
rewarming and a reduction in MAP after rewarming. There was also a higher lethality 
among these animals.  
 
Fluid treatment: 
Fluid resuscitation is important in treating intensive care patients with impaired 
circulation. Guidelines on treatment during hypothermia recommend the use of 
Ringer Acetate instead of NaCl due to fear of chloride overload inducing further 
metabolic acidosis(35). Preliminary data from Nilsen. et. al show improved CO, SV 
and reduced TPR in rats treated with the colloid fluid Dextran during rewarming. He 
concluded that the increased colloid pressure from Dextran infusion helped increase 
circulating blood volume and thus improving SV and CO.  
 
Anti-arrhythmic drugs: 
The prevention of arrhythmias during rewarming has been extensively studied. The 
importance of avoiding arrhythmia during rewarming is emphasized in the new 
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guidelines from University Hospital of Northern-Norway. Despite the central role 
antiarrhythmetics generally play in cardiology and emergency medicine, studies on 
common antiarrhythmic drugs like amiodarone, diltiazem and bretylium tosylate 
(80,81)  have all failed to prevent ventricular fibrillation during rewarming. 
Amiodarone also fails to improve survival in hypothermic patients with 
arrhythmias(82). Furthermore, studies conducted to look at the effect on 
antiarrhythmic drugs to lower defibrillation threshold in ventricular fibrillation found 
no effect of antiarrhythmic drugs(83).  
 
Summary 
With the use of guidelines the treatment of hypothermic patients have been more 
standardized and evidence based. A recurring issue in pharmacological treatment of 
hypothermic patients is the alteration in pharmacokinetics and –dynamics. 
Consequently, this necessitates re-testing of drugs that are known to have a beneficial 
effect in normothermi. The last chapter has shown a handful of these experiments. 
Discoveries like that epinephrine lack beneficial effect in hypothermic patients or the 
lack of antiarrhythmic effect of antiarrhythmics are examples of the importance of 
experiments like this. This shows that there is more need to study how hypothermia 
alternates the effect of common used intensive care drugs.  
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Chapter 7 
Thesis conclusion  
Our understanding of hypothermia has increased over the past 20-30 year. The 
knowledge that hypothermia alters human physiology has been known for quite some 
time, but new ground has been broken with respect to understanding the mechanisms 
of how hypothermia changes human physiology and how this give rise to clinical 
complications. The increase in mechanistic understanding has improved the treatment 
of hypothermic patients and resulted in a reduction in total mortality from 80% to 
30%. The impressive clinical examples of profoundly hypothermic patients being 
treated to complete recovery are a testimony to this.  
 
Although the mortality of hypothermia is low, and increased survival rate, the 
importance of body temperature in elderly and trauma patients cannot be stressed 
enough. Despite an impressive decrease in lethality, these two groups of patients still 
have a poor chance of survival compared to other hypothermic patients. Despite the 
importance of comorbidity in hypothermia, little research focus has been directed on 
this interplay. How the underlying mechanisms of hypothermia interact with 
pathological mechanisms in different comorbid conditions in the chronically ill is 
unknown. In the same manner new guidelines and treatment algorithms now 
emphasize temperature and circulatory stability. Future guidelines might also 
implement comorbidities when assessing the medical severity in a hypothermic 
patient.  
 
Despite great leaps in understanding underlying pathophysiology and mechanisms, 
we have only scratched the surface and much research is still needed. We now know 
there is a cardiac dysfunction associated with rewarming and many of the possible 
underlying mechanisms have been uncovered. The research on the hypothermic heart 
has lead to improved treatment by discovering how ubiquitously used drugs like 
epinephrine and amiodarone are detrimental to cardiac function in hypothermia. 
These finding help improve guidelines and move research forwards.  
 
The focus on complications of accidental hypothermia has been on how the heart is 
affected by hypothermia. This makes sense in the emergency room, due to the 
importance of cardiac function. As described, hypothermia induces organ dysfunction 
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and failure. The underlying mechanisms to describe how and why this happens are 
still unknown. The body of scientific evidence on hypothermia-associated contractile 
dysfunction has led to new and improved. One can only assume that further research 
on mechanisms underlying organ dysfunction in other systems will provide new 
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